Total planned funding: $835,238,440
Allocations
Countries/Regions
Kenya | $180,851,550 |
South Africa | $135,284,947 |
Uganda | $113,502,834 |
Zambia | $96,469,520 |
Tanzania | $70,178,120 |
Nigeria | $46,771,797 |
Côte d'Ivoire | $43,587,833 |
Ethiopia | $29,464,213 |
Mozambique | $18,108,350 |
Cameroon | $12,167,242 |
Lesotho | $9,530,129 |
Zimbabwe | $9,223,642 |
Malawi | $9,194,632 |
Democratic Republic of the Congo | $9,141,130 |
Haiti | $7,543,911 |
Eswatini | $7,135,512 |
Ukraine | $4,425,824 |
Namibia | $3,616,063 |
Vietnam | $3,603,245 |
Rwanda | $3,200,690 |
India | $3,034,838 |
Botswana | $2,866,302 |
Burundi | $2,277,761 |
Cambodia | $1,968,839 |
Ghana | $1,842,067 |
Central America Region | $1,601,970 |
Burma | $1,550,000 |
South Sudan | $1,337,000 |
China | $1,231,005 |
Russia | $1,100,000 |
Dominican Republic | $1,003,887 |
Caribbean Region | $754,272 |
Papua New Guinea | $422,656 |
Thailand | $416,191 |
Asia Regional Program | $395,926 |
Indonesia | $275,351 |
Guyana | $116,626 |
Central Asia Region | $42,565 |
Organizational Types
Unknown | $835,238,440 |
Program Areas
Treatment | $835,238,440 |
Budget Codes
HTXS: Treatment: Adult Treatment | $578,592,356 |
HTXD: Treatment: ARV Drugs | $190,043,754 |
PDTX: Treatment: Pediatric Treatment | $66,602,330 |
Top Partner Programs
Not Available:
$835,238,440
View countries